Apogee Therapeutics Inc (APGE)
NASDAQ
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-13 | Dr. Michael Thomas HendersonCEO & Director | -20.00k | 1.64M | Automatic Disposition | 82.05 - 82.58 | 1.07M | -1.84% |
| 2026-05-06 | Dr. Carl Linden DambkowskiChief Medical Officer | -4.13k | 252.16k | Derivative Exercise and Sale | 22.86 - 84.60 | 165.14k | - |
| 2026-05-06 | Dr. Carl Linden DambkowskiChief Medical Officer | -1.38k | 116.33k | Automatic Disposition | 84.60 | 165.14k | -0.83% |
| 2026-05-01 | Ms. Jane Pritchett V. HendersonCFO | -2.00k | 164.08k | Automatic Disposition | 81.02 - 83.16 | 173.37k | -1.14% |
| 2026-04-16 | Dr. Michael Thomas HendersonCEO & Director | 3.00k | 68.58k | Derivative Exercise and Retained Stock | 22.86 | 1.06M | 0.28% |
| 2026-04-16 | Ms. Jane Pritchett V. HendersonCFO | -2.00k | 180.00k | Automatic Disposition | 90.00 | 175.37k | -1.13% |
| 2026-04-08 | Dr. Michael Thomas HendersonCEO & Director | -20.00k | 1.65M | Automatic Disposition | 82.48 - 85.00 | 1.05M | -1.86% |
| 2026-04-01 | Dr. Carl Linden DambkowskiChief Medical Officer | -4.13k | 254.94k | Derivative Exercise and Sale | 22.86 - 85.33 | 153.98k | - |
| 2026-04-01 | Dr. Carl Linden DambkowskiChief Medical Officer | -1.38k | 117.38k | Automatic Disposition | 85.33 - 85.89 | 153.98k | -0.89% |
| 2026-04-01 | Ms. Jane Pritchett V. HendersonCFO | -2.00k | 170.02k | Automatic Disposition | 84.46 - 85.46 | 177.37k | -1.12% |
| 2026-03-25 | Ms. Jane Pritchett V. HendersonCFO | -2.00k | 170.00k | Automatic Disposition | 85.00 | 179.37k | -1.10% |
| 2026-03-11 | Dr. Michael Thomas HendersonCEO & Director | -20.00k | 1.50M | Automatic Disposition | 74.29 - 75.86 | 1.02M | -1.93% |
| 2026-03-04 | Dr. Carl Linden DambkowskiChief Medical Officer | -1.38k | 99.23k | Automatic Disposition | 71.98 - 73.26 | 155.36k | -0.88% |
| 2026-03-04 | Dr. Carl Linden DambkowskiChief Medical Officer | -4.13k | 197.30k | Derivative Exercise and Sale | 22.86 - 71.98 | 155.36k | - |
| 2026-03-02 | Ms. Jane Pritchett V. HendersonCFO | -2.00k | 140.43k | Automatic Disposition | 68.27 - 71.66 | 181.37k | -1.09% |
| 2026-02-11 | Dr. Michael Thomas HendersonCEO & Director | -20.00k | 1.27M | Automatic Disposition | 62.96 - 64.99 | 1.01M | -1.95% |
| 2026-02-04 | Dr. Carl Linden DambkowskiChief Medical Officer | -4.13k | 175.12k | Derivative Exercise and Sale | 22.86 - 66.85 | 150.47k | - |
| 2026-02-04 | Dr. Carl Linden DambkowskiChief Medical Officer | -1.38k | 92.44k | Automatic Disposition | 66.85 - 68.94 | 150.47k | -0.91% |
| 2026-02-02 | Ms. Jane Pritchett V. HendersonCFO | -2.00k | 131.63k | Automatic Disposition | 65.21 - 66.89 | 183.37k | -1.08% |
| 2026-01-22 | Fairmount Funds Management LLC法人 | -1.75M | 133.53M | 売り | 76.30 | 298.65k | -85.42% |
| 2026-01-14 | Dr. Michael Thomas HendersonCEO & Director | -20.00k | 1.62M | Automatic Disposition | 78.64 - 83.79 | 989.94k | -1.98% |
| 2026-01-07 | Dr. Carl Linden DambkowskiChief Medical Officer | -14.03k | 769.66k | Derivative Exercise and Sale | 22.86 - 77.90 | 145.58k | - |
| 2026-01-07 | Dr. Carl Linden DambkowskiChief Medical Officer | -4.68k | 365.34k | Automatic Disposition | 77.90 - 80.06 | 145.58k | -3.11% |
| 2026-01-02 | Ms. Jane Pritchett V. HendersonCFO | -8.00k | 609.15k | Automatic Disposition | 74.13 - 80.00 | 185.37k | -4.14% |
| 2025-12-19 | Ms. Jane Pritchett V. HendersonCFO | -1.50k | 120.00k | Automatic Disposition | 80.00 | 193.37k | -0.77% |
| 2025-12-10 | Dr. Michael Thomas HendersonCEO & Director | -20.00k | 1.51M | Automatic Disposition | 74.88 - 76.58 | 1.01M | -1.94% |
| 2025-12-04 | Dr. Carl Linden DambkowskiChief Medical Officer | -10.90k | 817.50k | Automatic Disposition | 75.00 | 197.89k | -5.22% |
| 2025-12-04 | Ms. Jane Pritchett V. HendersonCFO | -1.50k | 112.50k | Automatic Disposition | 75.00 | 194.87k | -0.76% |
| 2025-12-04 | Dr. Michael Thomas HendersonCEO & Director | -40.00k | 3.00M | Automatic Disposition | 75.01 | 1.03M | -3.74% |
| 2025-11-25 | Ms. Jane Pritchett V. HendersonCFO | -1.50k | 105.00k | Automatic Disposition | 70.00 | 196.37k | -0.76% |
| 2025-11-14 | Ms. Jane Pritchett V. HendersonCFO | -2.00k | 130.00k | Automatic Disposition | 65.00 | 197.87k | -1.00% |
| 2025-11-11 | Ms. Jane Pritchett V. HendersonCFO | -1,000.00 | 60.00k | Automatic Disposition | 60.00 | 199.87k | -0.50% |
| 2025-11-13 | Dr. Michael Thomas HendersonCEO & Director | -20.00k | 1.26M | Automatic Disposition | 61.93 - 64.52 | 1.04M | -1.89% |
| 2025-11-05 | Dr. Carl Linden DambkowskiChief Medical Officer | -8.06k | 257.57k | Derivative Exercise and Sale | 22.86 - 55.58 | 196.26k | - |
| 2025-11-05 | Dr. Carl Linden DambkowskiChief Medical Officer | -2.73k | 152.09k | Automatic Disposition | 55.58 - 56.51 | 196.26k | -1.37% |
| 2025-10-10 | Mr. Nimish P. ShahIndependent Director | 365.85k | 0.00 | Open Market Derivative Acquisition | - | 365.85k | - |
| 2025-10-01 | Dr. Carl Linden DambkowskiChief Medical Officer | -2.39k | 40.40k | Derivative Exercise and Sale | 22.86 - 39.80 | 198.99k | - |
| 2025-10-01 | Dr. Carl Linden DambkowskiChief Medical Officer | -2.73k | 108.46k | Automatic Disposition | 39.80 | 198.99k | -1.35% |
| 2025-09-03 | Dr. Carl Linden DambkowskiChief Medical Officer | -2.73k | 103.20k | Automatic Disposition | 37.82 - 38.55 | 141.54k | -1.89% |
| 2025-08-06 | Dr. Carl Linden DambkowskiChief Medical Officer | -2.73k | 102.95k | Automatic Disposition | 37.78 | 131.73k | -2.03% |
| 2025-07-02 | Dr. Carl Linden DambkowskiChief Medical Officer | -7.37k | 162.06k | Derivative Exercise and Sale | 22.86 - 45.49 | 134.45k | - |
| 2025-07-02 | Dr. Carl Linden DambkowskiChief Medical Officer | -2.73k | 124.53k | Automatic Disposition | 45.49 - 46.26 | 134.45k | -1.99% |
| 2025-06-04 | Dr. Carl Linden DambkowskiChief Medical Officer | -2.73k | 100.72k | Automatic Disposition | 36.96 | 124.64k | -2.14% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。